Trial Profile
A phase I/II study of carboplatin and navelbine [vinorelbine] for advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Sep 2005
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Sep 2005 New trial record.